Dr Vivek Arora


About Me

Dr Vivek Arora is a Specialist Gynaecologist and Certified Gynaecological Oncologist (CGO). He is an eminently experienced gynaecologist with a subspecialty interest and expertise in the treatment of gynaecological cancer, complex gynaecological & laparoscopic surgery, colposcopy for abnormal cervical screening test (CST) or Pap smears and the treatment of pre-cancerous conditions of cervix.

Dr Arora trained in laparoscopic (“key hole”) surgery and has significant experience in complex laparoscopic surgery for benign and malignant gynaecological conditions. He has undertaken multiple international certification training fellowships and provides an on-going role in medical and surgical research.

Surgical & Academic Experience

Dr Arora underwent training and clinical work experience in gynaecology and gynaecological oncology in Australia, the United Kingdom, India and Germany. He has worked as a Consultant Gynaecological Oncologist in Melbourne and Sydney.

Dr Arora is involved with many national and international initiatives to improve treatment outcomes of women diagnosed with gynaecological cancer. He is a Adjunct Senior Lecturer with University of New South Wales. He is former Director of Gynaecological Oncology at the Royal Hospital for Women, Randwick.


Certified Gynaecological Oncologist (CGO), Royal Australian & New Zealand College of Obstetricians & Gynaecologists Melbourne, Australia (2014)
Fellow, Royal Australian & New Zealand College of Obstetricians and Gynaecologists (FRANZCOG) Melbourne, Australia (2008)
Fellow, Royal College of Obstetricians & Gynaecologists (FRCOG) London, UK (2018)
Fellowship in Radical Surgery for Ovarian Cancer, Charite Hospital Berlin, Germany (2013)
Fellowship in Gynaecologic Oncology, (CGO), Royal Australian & New Zealand College of Obstetricians and Gynaecologists Australia (2009 – 2013)
Doctor of Medicine, Obstetrics & Gynaecology (MD) (2003)
Diplomate National Board, Obstetrics & Gynaecology (DNB) (2002)
Bachelor of Medicine & Bachelor of Surgery (MBBS) (1998)

National and International Leadership Experience in Gynaecological Oncology

International Gynecologic Cancer Society (IGCS) Council Member
International Mentor for Qatar-Australian partnership under the IGCS Global Curriculum Program in Gynaecological Oncology Mentor, Australian
ASGO Research Grants Committee, Australia Chair
Visiting Scholar and Mentorship Program, IGCS Chair
IGCS Mentorship and Training Steering Committee Member
Project ECHO (Extension for Community Healthcare Outcomes) in Gynaecological Oncology Member


  • Current

    Co-ordinating Principal Investigator, Surgery in Ovarian Cancer – Quality of Life Evaluation Research, Australian Cohort (SOCQERoOZ Study)
    ‘Protocol for a multi-centre prospective observational cohort study to assess quality of life after surgical treatment for ovarian cancer’. An international multi centre quality of life study in collaboration with the Pan Birmingham

    Gynaecological Cancer Centre, the SOCQER-2 study.

  • Past

    Treatment related outcomes in stage IB2 cervical cancer following primary concurrent chemo-radiotherapy versus primary surgery – a cohort comparison study across two Australian Centres, ILP research project UNSW 2018

    Audit of surgical practice in the management of ovarian cancer
    Prospective audit 2014 – 2016, Royal Women’s Hospital, Melbourne

    Feasibility of sentinel node detection in endometrial cancer
    Protocol development and AI, Royal Women’s Hospital, Melbourne

    Factors associated with long term survival following management of borderline and malignant mucinous tumours of the ovary
    CGO research project, RANZCOG

    Evaluation of transdermal nitroglycerine as a tocolytic agent in preterm labour
    MD thesis, All India Institute of Medical Sciences, India

    Study of some epidemiological aspects of dental caries in Shirur
    Public health study, RHTC Shirur, India


  • Invited

    Arora V, Somashekhar SP. Essential surgical skills for a gynaecological oncologist. Invited publication for the 2018 International Federation of Gynecology and Obstetrics (FIGO) report. Int J Gynecol Obstet 2018; 143 (Suppl 2): 118-130

    Arora V
    , Hacker NF. Vulvar cancer. Reference module in Encyclopedia of Reproduction, second edition. Elsevier

    Arora V. Benign and malignant disorders of the ovary and the fallopian tube. In. Permezel M, Walker S, Kyprianou K, editors. Beischer & MacKay’s: Obstetrics, Gynaecology and the Newborn. 4th ed. Elsevier; 2015

    Arora V, Quinn MA. Endometrial Cancer. Best Prac Res Clin Obstet Gynaecol 2012; 26(3): 311- 324

  • Indexed and non-indexed

    Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer. Bonnita Werner, Nicole Yuwono, Jennifer Duggan, Dongli Liu, Catherine David, Sivatharsny Srirangan, Pamela Provan, for the INOVATe Investigators, Anna DeFazio, Vivek Arora, Rhonda Farrell, Yeh Chen Lee, Kristina Warton, Caroline Ford. Gynecologic Oncology 2021.

    Lin M, Nettle J, Arora V. Hysterectomy with müllerian duct anomaly. O&G Magazine (RANZCOG). Spring 2017

    Brownfoot FC, Hickey M, Ang WC, Arora V and McNally O. Complex atypical hyperplasia of endometrium: differences in outcome following conservative management of pre- and postmenopausal women. Reproductive Sciences 2014; 21(10): 1244-8

    Arora V, Nattress K, Philp S, Pather S, Dalrymple C, Atkinson A, Smirnova S, Cotterell S, Carter J. Patient Satisfaction with In-patient Care Provided by the Sydney Gynaecological Oncology Group. Patient Related Outcome Measures. 2010;1:179-184

    Carter J, Philp S, Arora V. Fast track surgery in the overweight and obese patient. International Journal of Clinical Medicine 2010; 1(1) : 64-69

    Carter J, Philp S, Arora V. Early discharge after major gynaecological surgery: advantages of fast track surgery. Open Journal of Obstetrics and Gynecology 2011; 1 : 1-5

    Pather S, Loadsman JA, Mansfield C, Rao A, Arora V, Philp S, Carter J. Perioperative outcomes after total laparoscopic hysterectomy compared with fast-track open hysterectomy – a retrospective case-control study. Aust NZJ Obstet Gynaecol 2011; 51(5): 393-396

    Arora V, Luckas M. Pseudo-membranous colitis, a complication of erythromycin and preterm prelabour rupture of membranes. BJOG 2006; 113:489-490

    Arora V. The estrogen free pill contraceptive: an overview. Obst & Gynae Today 2005; vol X(1): 58-61

    Dadhwal V, Mittal S, Kumar S, Arora V. Expectant management of ectopic pregnancy: analysis of four cases. JK Science: Journal of Medical Education and Research 2005; 7(3): 161-3

    Agarwal U, Arora V. Hormonal contraception in medical disorders. Indian Medical Gazette 2002; 36(9): 352-5

    Mittal S, Arora V. Management of gestational trophoblastic diseases. In. Early Pregnancy Haemorrhage. Ed. Dutta DK

    Agarwal U, Kriplani A, Arora V. Anterior transverse cervical rupture following intra-amniotic prostaglandin induced mid-trimester abortion. J Post grad Med 2002; 48: 71-2

    Dadhwal V, Kumar S, Sarkar C, Arora V, Mittal S. Squamous cell carcinoma in situ arising in mature cystic teratoma. Ind J Pathol Microbiol 2002; 45(3): 345-6

    Dadhwal V, Arora V, Mittal S, Kumar S, Singh R, Nellore V.. Subcutaneous fat in fetal abdomen and correlation with birth weight. Ultraound interventional 2002; 8 (4):158-160

    Dadhwal V, Kochar S, Mittal S, Kumar S, Agarwal S, Arora V, Barua A. Fetal gastrointestinal malformations. Indian J Pediatr 2001; 68(1): 27-30